Boundless Bio (BOLD) Change in Cash (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Change in Cash of -$385000.0 for Q1 2026, up 96.64% year-over-year from -$195785.9 in Q1 2025, and down 113.33% quarter-over-quarter from $2.9 million in Q4 2025.
Boundless Bio (BOLD) Change in Cash (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Change in Cash for 4 consecutive years, with -$385000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 96.64% year-over-year to -$385000.0; the TTM figure through Mar 2026 stood at $2.4 million (up 123.6% YoY), while the FY2025 annual figure was -$8.7 million, down 402.64% from the prior year.
- Change in Cash fell to -$385000.0 in Q1 2026 per BOLD's latest filing, from $2.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $20.3 million in Q2 2023 and bottomed at -$20.4 million in Q3 2023.
- Historically, Change in Cash has averaged $504538.5 across 4 years, with a median of $1.4 million in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash surged 143.49% — and 2025, when it tumbled 898.19%.
- Boundless Bio's Change in Cash stood at $2.7 million in 2023, then plunged by 596.97% to -$13.6 million in 2024, then surged by 121.19% to $2.9 million in 2025, then plunged by 113.33% to -$385000.0 in 2026.
- Business Quant data shows BOLD's Change in Cash at -$385000.0 in Q1 2026, $2.9 million in Q4 2025, and $283000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - | 2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | -385,000.00 |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 283,000.00 |
| Jun 30, 2025 | -420,000.00 |
| Mar 31, 2025 | -11.47 Mn |
| Dec 31, 2024 | -13.63 Mn |
| Sep 30, 2024 | 8.85 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | -20.35 Mn |
| Jun 30, 2023 | 20.29 Mn |
| Mar 31, 2023 | 10.11 Mn |